Janecka A - Search Results

1

Design, Synthesis and Functional Analysis of Cyclic Opioid Peptides with Dmt-Tic Pharmacophore.

Sarkar A, Adamska-Bartlomiejczyk A, Piekielna-Ciesielska J, Wtorek K, Kluczyk A, Borics A, Janecka A. Sarkar A, et al. Among authors: janecka a. Molecules. 2020 Sep 17;25(18):4260. doi: 10.3390/molecules25184260. Molecules. 2020. PMID: 32957550 Free PMC article.

2

Opioid receptors and their ligands.

Janecka A, Fichna J, Janecki T. Janecka A, et al. Curr Top Med Chem. 2004;4(1):1-17. doi: 10.2174/1568026043451618. Curr Top Med Chem. 2004. PMID: 14754373 Review.

3

Opioid peptides in cancer.

Fichna J, Janecka A. Fichna J, et al. Among authors: janecka a. Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):351-66. doi: 10.1023/B:CANC.0000031773.46458.63. Cancer Metastasis Rev. 2004. PMID: 15197335 Review.

4

Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs.

Fichna J, do-Rego JC, Costentin J, Chung NN, Schiller PW, Kosson P, Janecka A. Fichna J, et al. Among authors: janecka a. Biochem Biophys Res Commun. 2004 Jul 23;320(2):531-6. doi: 10.1016/j.bbrc.2004.05.202. Biochem Biophys Res Commun. 2004. PMID: 15219861

5

Conformationally restricted peptides as tools in opioid receptor studies.

Janecka A, Kruszynski R. Janecka A, et al. Curr Med Chem. 2005;12(4):471-81. doi: 10.2174/0929867053362983. Curr Med Chem. 2005. PMID: 15720255 Review.

6

Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs.

Janecka A, Fichna J, Kruszynski R, Sasaki Y, Ambo A, Costentin J, do-Rego JC. Janecka A, et al. Biochem Pharmacol. 2005 Dec 19;71(1-2):188-95. doi: 10.1016/j.bcp.2005.10.018. Epub 2005 Nov 10. Biochem Pharmacol. 2005. PMID: 16288997

7

[Opioid receptors and their selective ligands].

Piestrzeniewicz MK, Fichna J, Janecka A. Piestrzeniewicz MK, et al. Among authors: janecka a. Postepy Biochem. 2006;52(3):313-9. Postepy Biochem. 2006. PMID: 17201067 Review. Polish.

8

Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).

Fichna J, do-Rego JC, Chung NN, Lemieux C, Schiller PW, Poels J, Broeck JV, Costentin J, Janecka A. Fichna J, et al. Among authors: janecka a. J Med Chem. 2007 Feb 8;50(3):512-20. doi: 10.1021/jm060998u. J Med Chem. 2007. PMID: 17266203

9

[Dmt1, d-1-Nal3]morphiceptin, a novel opioid peptide analog with high analgesic activity.

Fichna J, do-Rego JC, Chung NN, Costentin J, Schiller PW, Janecka A. Fichna J, et al. Among authors: janecka a. Peptides. 2008 Apr;29(4):633-8. doi: 10.1016/j.peptides.2007.12.005. Epub 2007 Dec 23. Peptides. 2008. PMID: 18234394

10

Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2.

Perlikowska R, Gach K, Fichna J, Toth G, Walkowiak B, do-Rego JC, Janecka A. Perlikowska R, et al. Among authors: janecka a. Bioorg Med Chem. 2009 Jun 1;17(11):3789-94. doi: 10.1016/j.bmc.2009.04.046. Epub 2009 May 3. Bioorg Med Chem. 2009. PMID: 19435668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page